Nocturnal 8mg dexamethasone suppression test: A practical and accurate test for identification of the cause of endogenous Cushing's syndrome

British Journal of Clinical Practice

Volumn 50, Issue 1, 1996, Pages 9-13

  Sriussadaporn, S ^a,b   Ploybutr, S ^a   Peerapatdit, T ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; DIAGNOSTIC AGENT; GLUCOCORTICOID;

ADRENAL TUMOR; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ECTOPIC CORTICOTROPIN PRODUCTION; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; NIGHT; PRIORITY JOURNAL; ADOLESCENT; COMPARATIVE STUDY; MIDDLE AGED; PREDICTION AND FORECASTING; SENSITIVITY AND SPECIFICITY;

ACTH SYNDROME, ECTOPIC; ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGED; CUSHING SYNDROME; DEXAMETHASONE; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 0029666031     PISSN: 00070947     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Orth DN. Differential diagnosis of Cushing's syndrome. N Engl J Med 1991: 325: 957-959.
2. Liddle GW. Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing's syndrome. J Clin Endocrinol Metah 1960: 20: 1539-1561.
3. Gold EM. The Gushing syndromes: changing views of diagnosis and treatment. Ann Intern Med 1979: 90: 829-844.
4. Grapo L. Cushing's syndrome: a review of diagnostic tests. Metaholisml 1979: 28: 955-977.
5. Aron DC. Tyrell JB, Fitzgerald PA, Findling JW. Forsham PH. Cushing's syndrome: problems in diagnosis. Medicine 1981; 60: 25-35.
6. Hewlett TA, Rees LH, Besser GM. Cushing's syndrome. Clin Endoerinol Metah 1985: 14: 911-945.
7. Carpenter PC. Cushing's syndrome: update of diagnosis and management. Mayo ClinPmc 1986; 61: 49-58.
8. Carpenter PC. Diagnostic evaluation of Cushing's syndrome. Endocrinol Metah Clin North Am 1988; 17: 445-472.
9. Kaye TB, Crapo L. The Cushing's syndrome: an update on diagnostic tests. Ann Intern Med 1990: 112: 434-444.
10. Trainer PJ, Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome. Clin Endocrinol 1991; 34: 317-330.
11. Findling JW, Doppman JL. Biochemical and radiologie diagnosis of Cushing's syndrome. Endocrinol Metah Clin North Am 1994: 23: 511-537.
12. Taylor AL. Fishman LM. Corticotrophin-releasing hormone. N Engl J Med 1988; 319: 219-222.
13. Grossman AB. Howlett TA. Perry L et al. CRF in the differential diagnosis of Cushing's syndrome: a comparison with the dexamethasone suppression test. Clin Endocrinol 1988: 29: 167-178.
14. Oldfield EH. Doppman JL. Niemann LK et al. Petrosal sinus sampling with and without conicotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med 1991; 325: 897-905.
15. Flack MR. Oldfield EH. Cutler GB Jr et al. Urine free Cortisol in the high-dose dexamethasone suppression lest for the differential diagnosis of the Cushing's syndrome. Ann Intern Med 1992; 116: 211-217.
16. Aron DC, Tyrell JB. Fitzgerald PA. Forsham PH. The overnight high-dose dexamethasone suppression test: a rapid method of differential diagnosis in Cushing's syndrome (abstract). Harm Res 1980; 13: 334.
17. Tyrell JB. Findling JW. Aron DC. Fitzgerald PA. Forsham PH. An overnight high-dose dexamethasone suppression test for rapid differential diagnosis of Cushing's syndrome. Ann Intern Med 1986; 104: 180-186.
18. Bruno OD. Rossi MA, Contreras LN et al. Nocturnal high-dose dexamethasone suppression test in the aetiological diagnosis of Cushing's syndrome. Ada Endocri noKCopenhl 1985; 109: 158-162.
19. Mattingly D. A simple fluorometric method for the estimation ol free 11-hydroxy corticosteroids in human plasma. J Clin Palhol 1962: 15: 374-379.
20. Pal SB. Smith VK. A simple fluorometric method for the determination of unconjugated cortisol in human urine, din Chim Acta 1965; 12: 558-564.
21. Meikle AW. Dexamethasone suppression test: usefulness of simultaneous measurement of plasma cortisol and dexamethasone. Clin Endocrinol 1982: 16: 401-408.
22. Turski PA, Morton-Turski D. Magnetic resonance imaging of the pituitary gland and juxtasellar regions. In: Putman CE. Ravin CE. Eds. Textbook of ditignosn'c imaging. 2nd edn. Philadelphia: Saunders. 1994: 278-293.
23. de Herder WW. Uitterlinden P. Pieterman H et al. Pituitary tumor localization in patients with Cushing's disease by magnetic resonance imaging. Is there a place for petrosal sinus sampling? Clin Endocrinol 1994: 40: 87-92.
24. Escourolle H. Abecassis JP Bertaagna X et al. Comparison of computerized tomography and magnetic resonance imaging for the examination of the pituitary gland in patients with Cushing's disease. Clin Endocrinol 1993: 39: 307-313.
25. Bailey RE. Periodic hormonogenesis - a new phenomenon. Periodicity in function of a hormone-producing tumor in man. J Clin Endocrinol Metab 1971; 32: 317-327.
26. Olsen PS. Binder C. Kehlet H et al. Episodic variation in plasma corticosteroids in subjects with Cushing's syndrome of differing etiology. J Clin Endocrinol Metab 1973; 36: 906-910.
27. Hermus AR. Pieters GF. Smals AG et al. Transition from pituitary-dependent Cushing's syndrome. N Engl J Med 1988; 318: 966-970.
28. Samuels MH, Loriaux DL. Cushing's syndrome and the nodular adrenal gland. Endocrinol Metah Clin North Am 1994; 23: 555-569.